Presentations & Webinars

Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients Webcast

CD33 Program Expansion: Actimab-A + CLAG-M Conference Call

ASH 2017 Actimab-A Preliminary Phase 2 Results

ASH 2017 AWE Platform Results with Daratumumab

Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz

Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies

Webinar to Provide Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

Regulatory Perspective: Acute Leukemia Clinical Endpoints

• « Previous
• 1
• 2
• 3
• 4
• 5